Home / Centerstage / 2017 / december / Week 2 /
Israel-based pharmaceutical company Teva announces a restructuring plan that includes a reduction of 14,000 jobs globally. The two-year plan aims to cut costs by $3 billion by the end of 2019. The restructuring is part of Teva's effort to improve its financial performance in the face of challenges in the generic drug market.
Tuesday, 12 December, 2017